Wiley Bros. Aintree Capital, LLC Boston Scientific Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 58,205 shares of BSX stock, worth $5.85 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
58,205
Previous 56,016
3.91%
Holding current value
$5.85 Million
Previous $5.65 Million
10.64%
% of portfolio
0.05%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding BSX
# of Institutions
1,932Shares Held
1.27BCall Options Held
9.59MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.7 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.56 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.49 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.4 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $144B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...